Pittsburgh Gut Club - Alcoholic Hepatitis 11.12.24
Target Audience
Nurse
Nurse Practitioner
Physician
Physician Assistant
Additional Information
Diseases of Gut Brain Interaction
November 2, 2023 with William D. Chey, MD / University of Michigan
5:30 to 6:30 pm Networking & Exhibitor Reception
6:15 to 6:30 pm Visit Dinner Buffet
6:30 to 7:30 pm Lecture by Dr. Chey
7:30 to 8:00 pm Q&A and Discussion with Dr. Chey
8:00 pm Adjourn
Treatment Advancements: Advanced Endoscopy
May 7, 2024 with Uzma Siddiqui, MD / University of Chicago
5:30 to 6:30 pm Networking & Exhibitor Reception
6:15 to 6:30 pm Visit Dinner Buffet
6:30 to 7:30 pm Lecture by Dr. Siddiqui
7:30 to 8:00 pm Q&A and Discussion with Dr. Siddiqui
8:00 pm Adjourn
Treatment Advancements: Alcoholic Hepatitis
November 12, 2024 with Philippe Mathurin, MD, PhD / CRHU Lille, France
5:30 to 6:30 pm Networking & Exhibitor Reception
6:15 to 6:30 pm Visit Dinner Buffet
6:30 to 7:30 pm Lecture by Dr. Mathurin
7:30 to 8:00 pm Q&A and Discussion with Dr. Mathurin
8:00 pm Adjourn
Disclaimer Statement
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
The following relevant financial relationships were disclosed:
Philippe Mathurin, MD, PhD / CRHU Lille, France is a consultant for the following companies: AbbVie, Advanz Pharma Services, Agomab Therapeutics, AstraZeneca, Bayer Healthcare, Eisai, Evive Biotech, Gilead Science, GlaxoSmithKline, Iddi, Intercept, Ipsen, Novo Nordisk, Pfizer, Resolution Therapeutics
CME ACCREDITATION AND DESIGNATION STATEMENT
Accreditation and credit designation
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.50 Attendance
Price
$50